All Medical Microbiology articles
-
NewsSome guidelines for diagnosis and treatment of hepatitis E virus infection need a revamp, evaluation finds
A systematic evaluation of HEV infection guidelines revealed significant variability in their quality and recommendations. While some demonstrated strengths, others were found lacking in stakeholder involvement, rigor of development, and applicability.
-
NewsTriple antibody therapy shows promise for long-lasting HIV control
A cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV, a new study shows. Some participants showed long-term control of the virus months after antibody levels declined to low or undetectable.
-
NewsMachine learning could help reduce hospitalizations by nearly 30% during a pandemic, study finds
New research shows machine learning can be more effective than current methods to distribute scarce treatments to patients most vulnerable during a public health crisis.
-
NewsApplied Microbiology International teams up with SelectScience®
Applied Microbiology International (AMI) has announced a new partnership with laboratory science publisher SelectScience®. The two organisations will be working together on SelectScience’s upcoming CLINICAL24 campaign and beyond.
-
NewsConscience announces top performers in open science challenge to design promising pan-coronavirus drugs
The nonprofit drug discovery biotech Conscience has released seven newly discovered promising early-stage molecules that could lead to a new treatment effective against all coronaviruses, not just SARS-CoV-2.
-
NewsEmergency department screening more than doubles detection of syphilis cases
Providing optional syphilis tests to most people seeking care at a large emergency department led to a dramatic increase in syphilis screening and diagnosis, according to a study of nearly 300,000 emergency department encounters in Chicago.
-
NewsNew research illuminates the impact of surface properties on bacteria movement
A new study reveals the key role surface properties play in either enabling or preventing twitching motility, the process by which bacteria move across surfaces, allowing them to rapidly colonize new surfaces including those of tissues and medical implants.
-
NewsInnovative implant material combines osteogenic and antibacterial properties for superior bone repair
A new study introduces a novel polyetheretherketone (PEEK)-based implant material that not only promotes bone growth but also possesses potent antibacterial capabilities.
-
NewsWound peptides can help detect dangerous infections more quickly
After identifying unique peptide patterns and changes in these patterns based on different types of bacteria in wounds, researchers can now assess the severity of the infection, a new study reveals.
-
NewsNew guideline for Helicobacter pylori includes change to primary treatment recommendation
New guidelines on the treatment of Helicobacter pylori (H. pylori) infection warn against prescribing PPI triple therapy, instead advising practitioners to use bismuth quadruple therapy or one of the other suggested treatment options.
-
NewsFungus uses surface protein of its spores to weaken human immune system
An international research team discovered a special enzyme on the surface of the spores of Aspergillus fumigatus apparently suppresses the release of pro-inflammatory substances by immune cells, making it easier for the pathogen to spread in the tissue.
-
NewsPublic health experts put out call for collaboration in antiviral therapeutics development coalition
Establishing a global therapeutics development coalition is a vital next step to invigorate the therapeutics pipeline and drive advocacy for increased investment and coordination of end-to-end therapeutics development, say a group of public health experts.
-
NewsResearchers discover key gene regulating virulence of fungus that causes severe lung infections
Scientists have found a potential target for novel therapeutic strategies to combat fungal infections caused by Aspergillus fumigatus and are now looking for a molecule that inactivates the protein expressed by the gene as a basis for a drug.
-
NewsNew study provides insight to why Covid vaccines hit some harder than others
Scientists have highlighted factors that may explain why some people perceived more side effects from the SARS-CoV2 vaccine than others, including stress, exercise, and use of hormonal birth control.
-
NewsInfections following hip replacement associated with an increased risk of death, study finds
Patients who develop a periprosthetic joint infection (PJI) after a total hip replacement have more than a five-fold increased risk of mortality within 10 years, according to new research.
-
NewsSevere COVID-19 can involve either exacerbated lung inflammation or high viral replication
Researchers report a study based on autopsies of 47 patients who died after being infected by the ancestral strain of SARS-CoV-2. The findings will support clinical decisions on the treatment of critical cases.
-
NewsScientists seek more effective treatment for under-the-radar STI
Researchers at Tulane University are leading a groundbreaking study to seek a more effective treatment for trichomoniasis, an infection that, despite being the most common curable sexually transmitted infection (STI) worldwide, continues to fly under the radar.
-
NewsWaging war on ‘superbugs’ in aged care
A new study explores the link between the widespread use of antibiotics in residential aged care and the resulting antibiotic resistant bacteria in the gut that can be passed on to other residents
-
NewsResearchers take inspiration from viruses to improve delivery of nucleic acid-based therapies to cancer cells
A researcher is developing a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells.
-
News Scientists discover superbug’s rapid path to antibiotic resistance
Researchers have discovered how a hospital superbug Clostridioides difficile (C.diff) can rapidly evolve resistance to vancomycin. In less than two months the bacteria could develop resistance to 32 times the initial antibiotic concentration.
